Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Hochberg J, Cairo MS (2008) Tumor lysis syndrome: current perspective. Haematologica 93(1):9–13
2. Fassas AB, Desikan KR, Siegel D, Golper TA, Munshi NC, Barlogie B et al (1999) Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma. Br J Haematol 105(4):938–941
3. Arai A, Oshikawa G, Kurosu T, Miki T, Tohda S, Koyama T et al (2006) Bortezomib-induced tumor lysis syndrome with a remarkable elevation of LDH in a case of relapsed and therapy-resistant multiple myeloma. Rinsho Ketsueki 47(8):777–780
4. Field-Smith A, Morgan GJ, Davies FE (2006) Bortezomib (velcadetrade mark) in the treatment of multiple myeloma. Ther Clin Risk Manag 2(3):271–279
5. Furtado M, Rule S (2008) Bortezomib-associated tumor lysis syndrome in multiple myeloma. Leuk Lymphoma 49(12):2380–2382
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献